Showing results (511-520 of 532) with videos related to
Sort By:
Pageof 54
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 6, 2015
Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early resultsJ Puig-Barbera, A Mira-Iglesias, M Tortajada-Girbes, et al.Journal of the Peripheral Nervous System : JPNS|June 14, 2022
Electrodiagnostic subtyping in Guillain-Barré syndrome: Use of criteria in practice based on a survey study in IGOSSamuel Arends, Judith Drenthen, Peter Y K Van den Bergh, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 28, 2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopeniaJ A Mira, K Neukam, L F López-Cortés, et al.Epidemiology and Infection|October 27, 2016
Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in GermanyC Schwarze-Zander, R Draenert, C Lehmann, et al.Der Nervenarzt|August 23, 2022
[Public health situation of CIDP patients in nine German centers-neuritis network Germany]Anna Lena Fisse, Jeremias Motte, Thomas Grüter, et al.The Journal of Antimicrobial Chemotherapy|October 16, 2008
Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backboneJosé A Mira, Luis F López-Cortés, Pablo Barreiro, et al.Journal of the Peripheral Nervous System : JPNS|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.Physical Review Letters|May 7, 2003
Measurement of spin-correlation parameters ANN, ASS, and ASL at 2.1 GeV in proton-proton elastic scatteringF Bauer, J Bisplinghoff, K Büsser, et al.Molecular Cell|December 17, 2020
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRDGraeme Hewitt, Valerie Borel, Sandra Segura-Bayona, et al.European Journal of Neurology|October 10, 2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndromePieter A van Doorn, Peter Y K Van den Bergh, Robert D M Hadden, et al.Pageof 54